DPIIT and Thermo Fisher Scientific launch BioVerse challenge to fast-track India’s biotech future
India currently hosts more than 10,075 biotech startups
India currently hosts more than 10,075 biotech startups
82,514 sq ft facility to host up to 15 biotech companies, fueling the development of next-generation medicines
Bayer Co.Lab AdVenture platform will accelerate biotech innovation through global investment networks
Under the partnership, the Pfizer INDovation program will empower DPIIT-recognized startups with grants of up to Rs. 60 lakhs each, along with a tailored 18-month incubation program delivered by Social Alpha
In light of the contributions of these three institutes, it was decided to organize a CSIR Startup Conclave in Hyderabad. The event, scheduled for April 22–23, 2025
The freshly infused capital will primarily be deployed towards expansion and research & development
The initiative will encourage and motivate emerging biotech startups, innovators and entrepreneurs
The program aims to accelerate the development of 6 Indian innovations to improve ease of access to diagnostics and treatment monitoring
Critical resources will help Genvor to grow and scale biological crop protection products and innovative trait technologies
The fresh funds will be used to enhance customer relationships, expand operations and develop state-of-the-art service
The collaboration aims to bolster healthcare entrepreneurship
Pfizer INDovation program partners with NIPER Ahmedabad to incubate healthcare startups
At least one recognised startup in every State and UT; spread across over 80% of districts
SigTuple’s AI100 with Shonit is the premier solution for AI assisted digital pathology
Debut Biotechnology has outstanding enzyme search and design technology and a bio-manufacturing platform (precision fermentation, cell-free synthesis) using those enzymes
Campaign to celebrate World Mental Health Day theme "Mental Health in an Unequal World"
The startup plans to provide free technology to dental clinics upon registration.
GlobalData’s ‘Pharmaceutical Intelligence Center’ observes that India is still in the nascent stage of developing these potential therapies as currently only four cell/gene therapy molecules are being developed in the country.
Clinikk has raised $6.4 Million so far from marquee investors such as MassMutual Ventures, 500 Startups, Times Internet and prominent angels like Kunal Shah, Rohit MA, Rajan Anandan etc.
Subscribe To Our Newsletter & Stay Updated